MRX-8 is under clinical development by MicuRx Pharmaceuticals and currently in Phase I for Acinetobacter Infections.
Dr Lukas Burkhardt has been appointed to the management board of Gerresheimer effective 1 January. Lukas Burkhardt will assume responsibility for the primary packaging glass division. Chairman of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback